About Oxford MEStar
Oxford MEStar is a company based in Oxford (United Kingdom) founded in 2013 by Zhanfeng Cui.. Oxford MEStar has raised $929.86 thousand across 2 funding rounds. The company has 8 employees as of November 30, 2021. Oxford MEStar operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Oxford, United Kingdom
- Employees 8 as on 30 Nov, 2021
- Founders Zhanfeng Cui
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Oxford Mestar Limited
- Date of Incorporation 28 Oct, 2013
- Jurisdiction THAME, OXFORDSHIRE
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$929.86 K (USD)
in 2 rounds
-
Latest Funding Round
$523.63 K (USD), Seed
Aug 30, 2016
-
Investors
-
Employee Count
8
as on Nov 30, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Oxford MEStar
Oxford MEStar has successfully raised a total of $929.86K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $523.63 thousand completed in August 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Seed — $523,628
-
First Round
First Round
(16 Sep 2014)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2016 | Amount | Seed - Oxford MEStar | Valuation |
investors |
|
| Sep, 2014 | Amount | Seed - Oxford MEStar | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Oxford MEStar
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Oxford MEStar
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Oxford Mestar Comparisons
Competitors of Oxford MEStar
Oxford MEStar operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Oxford MEStar
When was Oxford MEStar founded?
Oxford MEStar was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Where is Oxford MEStar located?
Oxford MEStar is headquartered in Oxford, United Kingdom. It is registered at Oxford, Oxfordshire, United Kingdom.
Who is the current CEO of Oxford MEStar?
Robert Wang is the current CEO of Oxford MEStar.
Is Oxford MEStar a funded company?
Oxford MEStar is a funded company, having raised a total of $929.86K across 2 funding rounds to date. The company's 1st funding round was a Seed of $406.23K, raised on Sep 16, 2014.
How many employees does Oxford MEStar have?
As of Nov 30, 2021, the latest employee count at Oxford MEStar is 8.
What does Oxford MEStar do?
Developer of novel scaffolds for tissue engineering and stem cell delivery. The company has developed regenerative medicine and biomaterial products that help in drug delivery and formulation. It provides solutions for stem cell isolation, purification, culture, storage, and formulation under GMP for clinical applications. The company also develops in-vitro diagnostic tools that measure bowel health for the detection of invisible traces of blood in the stool and also offer PetAssist service for animal post-cancer treatment.
Who are the top competitors of Oxford MEStar?
Oxford MEStar's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.